Home » Sera Prognostics Closes $20M Series B Financing Round

Sera Prognostics Closes $20M Series B Financing Round

Jan 07, 2015
|
staff reporter

NEW YORK(GenomeWeb) – Sera Prognostics said today it has closed $20 million in Series B financing.

The round was led by European investment firm Chione, which is a new investor in the firm, and included current Sera investors Domain Associates, InterWest Partners, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

What's Popular?

In Proteomics & Protein Research

  1. IsoPlexis Uses Single-Cell Platform to Assess T Cell Activity in CAR-T Cancer Therapy

    Premium

  2. Advances in Mass Spec Push Single-Cell Proteomics Toward Feasibility

    Premium

  3. Protagen Shifting to Focus on Cancer Immunotherapy

    Premium

  4. Top Down Proteomics Identifies Protein-Level Effects of KRAS Mutations in Colorectal Cancer

    Premium

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.